Race
Sleep Heart Health Study (SHHS) Visit Number vs Days to First Percutaneous transluminal coronary angioplasty (PTCA) Since Baseline
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Visit 1 | - | - | - | - | - | - | - | - |
| Interim Follow-up Visit | - | - | - | - | - | - | - | - |
| Visit 2 | - | - | - | - | - | - | - | - |
| CVD Outcomes | 311 | 2,038.3 | ± 1,256.7 | 1,915.0 | 21.0 | 5,231.0 | 5,491 | 5,802 |
Gender of the participant vs Days to First Percutaneous transluminal coronary angioplasty (PTCA) Since Baseline
CVD Outcomes
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 311 | 2,038.3 | ± 1,256.7 | 1,915.0 | 21.0 | 5,231.0 | 5,491 | 5,802 |
| Male | 214 | 1,984.5 | ± 1,232.9 | 1,891.5 | 21.0 | 5,006.0 | 2,551 | 2,765 |
| Female | 97 | 2,157.0 | ± 1,306.3 | 1,952.0 | 33.0 | 5,231.0 | 2,940 | 3,037 |
Race of the participant vs Days to First Percutaneous transluminal coronary angioplasty (PTCA) Since Baseline
CVD Outcomes
| N | Mean | StdDev | Median | Min | Max | Unknown | Total | |
|---|---|---|---|---|---|---|---|---|
| Total | 311 | 2,038.3 | ± 1,256.7 | 1,915.0 | 21.0 | 5,231.0 | 5,491 | 5,802 |
| White | 282 | 2,062.3 | ± 1,253.9 | 1,959.0 | 21.0 | 5,231.0 | 4,625 | 4,907 |
| Black | 13 | 1,149.7 | ± 729.1 | 910.0 | 251.0 | 2,394.0 | 502 | 515 |
| Other | 16 | 2,337.8 | ± 1,403.1 | 2,017.0 | 441.0 | 4,748.0 | 364 | 380 |